Portable & Mobile ECG Devices Market

Global Portable & Mobile ECG Devices Market Size, Trends & Analysis - Forecasts to 2027 By Modality (Table-top EEG Device, Wearable EEG Device, Handheld EEG Device), By Application (Monitoring ECG Devices, Diagnostic ECG Devices), By Grade Type (Medical-Grade, Consumer-Grade), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on November 29 2022 with the latest and most recent market numbers

Portable & Mobile ECG Devices Market Size

The global portable & mobile ECG devices market is projected to grow at a CAGR value of 6.5% from 2022 to 2027.

According to the World Health Organization (WHO), 60% of the world’s population suffers from cardiovascular related diseases. The electrocardiogram (ECG) evaluates the heart’s condition and helps the patient understand more about their heart’s health. Heart diseases do not take place at a scheduled time but are rather unpredictable and possibly fatal to the patient’s health. The portable and mobile ECG device is a modern-day device which would help monitor these sudden attacks or distress in the heart’s functioning. Along with being a time-saver, portable and mobile ECG devices are compact, simple to operate, cost-effective with result viewable on laptops and smartphones.

The global portable & mobile ECG devices market is highly driven by a growing population of CVD patients who require daily monitoring, rising geriatric population, increasing usage of technology-based healthcare, increasing healthcare expenses and growing demand for in-home healthcare devices.

Furthermore, increasing demand for hospital stay and rising investments by governments in the healthcare devices sector are also some of the factors propelling the growth of portable and mobile ECG devices.

Research and development in the portable and mobile ECG device are taking place rapidly. Data collected in the portable and mobile ECG devices are precise and specific to the patient. Due to development in the efficiency of the device, the device can help doctors to check the patient’s heart condition remotely via a smartphone. Portable and mobile ECG devices are being manufactured keeping in mind the compactness of the device. Scientists have created portable ECG devices such as watches that are wearable and can keep a track of the patient’s heart health.

The COVID-19 pandemic has encouraged individuals to direct their attention towards at-home healthcare devices. Individuals who require regular healthcare routine check-up have resorted to use portable and mobile ECG devices in order to reduce the risk of catching the virus. Doctors and the medical staff have also promoted the usage of in-home healthcare devices in order to reduce the burden of the healthcare sector, which was facing staff and healthcare device shortages. Doctors can remotely access the data collected by the portable ECG device on their smartphones and other electronic devices. The rise in telemedicine has increased the usage of portable and mobile ECG devices and have made the lives of both doctors and patients easier. Manufacturers have found the pandemic situation to be a conducive environment for the production and sale of the devices.

global portable & mobile ecg devices market

Portable & Mobile ECG Devices Market: By Modality

Based on the Modality, the portable & mobile EEG devices market is divided into tabletop EEG device (medical grade), wearable EEG device (consumer grade), handheld EEG device (consumer grade). The handheld EEG device segment is expected to be the largest segment in the market from 2022 to 2027.

Handheld EEG device give instant results and can collect accurate results which can saved on smartphones, laptop devices etc. The device is portable, compact, cost-effective and can be taken to any destination as per the convenience of the individual.

Portable & Mobile ECG Devices Market: By Application

Based on the application, the portable & mobile ECG devices market is divided into monitoring CG devices and diagnostic ECG devices. The monitoring ECG devices segment is expected to be the largest segment in the market from 2022 to 2027.

Monitoring ECG devices keep a constant track of the variabilities in the heart rate while providing analysis of the data collected to doctors remotely. The benefit of the monitoring ECG device is its constantly tracking feature which detects irregularity in the heart rate in its early stages and helps the patient to take swift action against any future health related diseases.

Portable & Mobile ECG Devices Market: By Grade-Type

Based on the grade type, the portable & mobile ECG devices market is divided into medical-grade and consumer-grade. The consumer-grade segment is expected to be the fastest growing segment in the market. This is mainly attributed to the rising demand for at-home monitoring devices, point of care treatment methods, and rising need for minimally invasive diagnostic procedures.

asia pacific portable & mobile ecg devices market

Portable & Mobile ECG Devices Market: By Region

As per the geographical analysis, the portable & mobile ECG devices market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico) will have a dominant share in the Portable & Mobile ECG Devices market from 2022 to 2027. The major factor driving the growth of the market in the North American region are rising cases of heart-related diseases among the population, increasing health-consciousness, rise in inactive and unhealthy lifestyles and government investments in portable and mobile ECG device making companies are the factors for the growth of the device in the region.

Moreover, the Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific) region is expected to be the fastest-growing segment in the portable & mobile ECG devices market during the forecast period. Rapidly rising geriatric population, increasing demand for in-home healthcare devices in place of hospital visits and increasing adoption technology in healthcare are factors for increasing usage of portable & mobile ECG devices in the region.

Portable & Mobile ECG Devices Market Share and Competitor Analysis

Wellue, Biocare, Eko Health, Vital Connect, Qardio, Visi, Lifewatch, Emay, MD Biomedical, Inc., General Electric Company, Thor Laboratories, CardioComm Solutions, Inc., GETMED Medizin-und Informationstechnik AG, Koninklijke Philips N.V, BPL Medical Technologies, AliveCor Inc., Nihon Kohden Corporation, EB Neuro S.p.A, FaceLake, PocketECG, Spandan, Dr Trust USA, Contec Health among others are the key players in the portable & mobile ECG devices market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Portable & Mobile ECG Devices Industry Overview, 2022-2027

2.1.1    Industry Overview

2.1.2    Modality Overview

2.1.3    Application Overview

2.1.4    Grade Type Overview

2.1.5    Connectivity Overview

2.1.6    Regional Overview

Chapter 3   Portable & Mobile ECG Devices Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2022-2027

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Advancements in the portable healthcare devices

3.3.1.2    Growing dependence on in-home healthcare devices in APAC region

3.3.2    Industry Challenges

3.3.2.1    Lack of provision of sufficient information

3.4    Prospective Growth Scenario

3.4.1    Modality Growth Scenario

3.4.2    Application Growth Scenario

3.4.3    Grade Type Growth Scenario

3.4.4    Connectivity Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.8.1    North America

3.8.2    Europe

3.8.3    APAC

3.8.4    LATAM

3.8.5    MEA

3.10    Connectivity Overview

3.11    Market Share Analysis, 2022

3.11.1    Company Positioning Overview, 2022

Chapter 4   Portable & Mobile ECG Devices Market, By Modality

4.1    Modality Outlook

4.2    Tabletop EEG Device (Medical Grade)

4.2.1    Market Size, By Region, 2022-2027 (USD Million)

4.3    Wearable EEG Device (Consumer Grade)

4.3.1    Market Size, By Region, 2022-2027 (USD Million)

4.4    Handheld EEG Device (Consumer Grade)

4.4.1    Market Size, By Region, 2022-2027 (USD Million)

Chapter 5   Portable & Mobile ECG Devices Market, By Grade Type

5.1    Grade Type Outlook

5.2    Medical-Grade

5.2.1    Market Size, By Region, 2022-2027 (USD Million)

5.3    Consumer-Grade

5.3.1    Market Size, By Region, 2022-2027 (USD Million)

Chapter 6   Portable & Mobile ECG Devices Market, By Application

6.1    Monitoring ECG Devices

6.1.1    Market Size, By Region, 2022-2027 (USD Million)

6.2    Diagnostic ECG Devices

6.2.1    Market Size, By Region, 2022-2027 (USD Million)

Chapter 7   Portable & Mobile ECG Devices Market, By Region

7.1    Regional outlook

7.2    North America

7.2.1    Market Size, By Country 2022-2027 (USD Million)

7.2.2    Market Size, By Modality, 2022-2027 (USD Million)

7.2.3    Market Size, By Application, 2022-2027 (USD Million)

7.2.4    Market Size, By Grade Type, 2022-2027 (USD Million)

7.2.6    U.S.

7.2.6.1    Market Size, By Modality, 2022-2027 (USD Million)

7.2.4.2    Market Size, By Application, 2022-2027 (USD Million)

7.2.4.3    Market Size, By Grade Type, 2022-2027 (USD Million)

Market Size, By Connectivity, 2022-2027 (USD Million)

7.2.7    Canada

7.2.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.2.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.2.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3    Europe

7.3.1    Market Size, By Country 2022-2027 (USD Million)

7.3.2    Market Size, By Modality, 2022-2027 (USD Million)

7.3.3    Market Size, By Application, 2022-2027 (USD Million)

7.3.4    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.6    Germany

7.3.6.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.6.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.6.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.7    UK

7.3.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.8    France

7.3.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.7.4    Market Size, By Connectivity, 2022-2027 (USD Million)

7.3.9    Italy

7.3.8.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.8.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.8.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.10    Spain

7.3.10.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.10.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.10.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.3.11    Russia

7.3.11.1    Market Size, By Modality, 2022-2027 (USD Million)

7.3.11.2    Market Size, By Application, 2022-2027 (USD Million)

7.3.11.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market Size, By Country 2022-2027 (USD Million)

7.4.2    Market Size, By Modality, 2022-2027 (USD Million)

7.4.3    Market Size, By Application, 2022-2027 (USD Million)

7.4.4    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4.6    China

7.4.6.1    Market Size, By Modality, 2022-2027 (USD Million)

7.4.6.2    Market Size, By Application, 2022-2027 (USD Million)

7.4.6.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4.7    India

7.4.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.4.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.4.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4.8    Japan

7.4.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.4.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.4.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4.9    Australia

7.4.8.1    Market Size, By Modality, 2022-2027 (USD Million)

7.4.8.2    Market size, By Application, 2022-2027 (USD Million)

7.4.8.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.4.10    South Korea

7.4.10.1    Market Size, By Modality, 2022-2027 (USD Million)

7.4.10.2    Market Size, By Application, 2022-2027 (USD Million)

7.4.10.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.5    Latin America

7.5.1    Market Size, By Country 2022-2027 (USD Million)

7.5.2    Market Size, By Modality, 2022-2027 (USD Million)

7.5.3    Market Size, By Application, 2022-2027 (USD Million)

7.5.4   Market Size, By Grade Type, 2022-2027 (USD Million)

7.5.6    Brazil

7.5.6.1    Market Size, By Modality, 2022-2027 (USD Million)

7.5.6.2    Market Size, By Application, 2022-2027 (USD Million)

7.5.6.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.5.7    Mexico

7.5.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.5.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.5.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.5.8    Argentina

7.5.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.5.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.5.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.6    MEA

7.6.1    Market Size, By Country 2022-2027 (USD Million)

7.6.2    Market Size, By Modality, 2022-2027 (USD Million)

7.6.3    Market Size, By Application, 2022-2027 (USD Million)

7.6.4    Market Size, By Grade Type, 2022-2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market Size, By Modality, 2022-2027 (USD Million)

7.6.6.2    Market Size, By Application, 2022-2027 (USD Million)

7.6.6.3   Market Size, By Grade Type, 2022-2027 (USD Million)

7.6.7    UAE

7.6.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.6.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.6.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

7.6.8    South Africa

7.6.7.1    Market Size, By Modality, 2022-2027 (USD Million)

7.6.7.2    Market Size, By Application, 2022-2027 (USD Million)

7.6.7.3    Market Size, By Grade Type, 2022-2027 (USD Million)

Chapter 8   Company Landscape

8.1    Competitive Analysis, 2022

8.2    Wellue

8.2.1    Company Overview

8.2.2    Financial Analysis

8.2.3    Strategic Positioning

8.2.4    Info Graphic Analysis

8.3    Biocare

8.3.1    Company Overview

8.3.2    Financial Analysis

8.3.3    Strategic Positioning

8.3.4    Info Graphic Analysis

8.4    Eko Health

8.4.1    Company Overview

8.4.2    Financial Analysis

8.4.3    Strategic Positioning

8.4.4    Info Graphic Analysis

8.5    Vital Connect

8.5.1    Company Overview

8.5.2    Financial Analysis

8.5.3    Strategic Positioning

8.5.4    Info Graphic Analysis

8.6    Qardio

8.6.1    Company Overview

8.6.2    Financial Analysis

8.6.3    Strategic Positioning

8.6.4    Info Graphic Analysis

8.7    Visi

8.7.1    Company Overview

8.7.2    Financial Analysis

8.7.3    Strategic Positioning

8.7.4    Info Graphic Analysis

8.8    Lifewatch

8.7.1    Company Overview

8.7.2    Financial Analysis

8.7.3    Strategic Positioning

8.7.4    Info Graphic Analysis

8.9    Emay

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Info Graphic Analysis

8.10    MD Biochemical, Inc.

8.10.1    Company Overview

8.10.2    Financial Analysis

8.10.3    Strategic Positioning

8.10.4    Info Graphic Analysis

8.11    General Electric Company

8.11.1    Company Overview

8.11.2    Financial Analysis

8.11.3    Strategic Positioning

8.11.4    Info Graphic Analysis

8.12    Thor Laboratories

8.12.1    Company Overview

8.12.2    Financial Analysis

8.12.3    Strategic Positioning

8.12.4    Info Graphic Analysis

8.13   CardioComm Solutions, Inc.

8.13.1    Company Overview

8.13.2    Financial Analysis

8.13.3    Strategic Positioning

8.13.4    Info Graphic Analysis

8.14    GETEMED Medizin-und informationstechnik AG

8.14.1    Company Overview

8.14.2    Financial Analysis

8.14.3    Strategic Positioning

8.14.4    Info Graphic Analysis

8.15    Koninklijke Philips N.V

8.15.1    Company Overview

8.15.2    Financial Analysis

8.15.3    Strategic Positioning

8.15.4    Info Graphic Analysis

8.16    BPL Medical Technologies

8.16.1    Company Overview

8.16.2    Financial Analysis

8.16.3    Strategic Positioning

8.16.4    Info Graphic Analysis

8.17    AliveCor, Inc.

8.17.1    Company Overview

8.17.2    Financial Analysis

8.17.3    Strategic Positioning

8.17.4    Info Graphic Analysis

8.18   Nihon Kohden Corporation

8.17.1    Company Overview

8.17.2    Financial Analysis

8.17.3    Strategic Positioning

           8.17.4    Info Graphic Analysis

8.19    EB Neuro S.p.A

8.18.1    Company Overview

8.18.2    Financial Analysis

8.18.3    Strategic Positioning

           8.18.4    Info Graphic Analysis

8.20    FaceLake

8.20.1    Company Overview

8.20.2    Financial Analysis

8.20.3    Strategic Positioning

           8.20.4    Info Graphic Analysis

8.21    PocketECG

8.21.1    Company Overview

8.21.2    Financial Analysis

8.21.3    Strategic Positioning

8.21.4    Info Graphic Analysis

8.22    Spandan

8.22.1    Company Overview

8.22.2    Financial Analysis

8.22.3    Strategic Positioning

           8.22.4    Info Graphic Analysis

8.23    Dr Trust USA

8.23.1    Company Overview

8.23.2    Financial Analysis

8.23.3    Strategic Positioning

           8.23.4    Info Graphic Analysis

8.24    Contec Health

8.24.1    Company Overview

8.24.2    Financial Analysis

8.24.3    Strategic Positioning

           8.24.4    Info Graphic Analysis

8.25    Others

8.25.1    Company Overview

8.25.2    Financial Analysis

8.25.3    Strategic Positioning

           8.25.4    Info Graphic Analysis

The Global Portable & Mobile ECG Devices Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Portable & Mobile ECG Devices Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The portable & mobile ECG devices market is projected to grow at a CAGR value of 6.5% from 2022 to 2027.
Wellue, Biocare, Eko Health, Vital Connect, Qardio, Visi, Lifewatch, Emay, MD Biomedical, Inc., General Electric Company, Thor Laboratories, CardioComm Solutions, Inc., GETMED Medizin-und Informationstechnik AG, Koninklijke Philips N.V, BPL Medical Technologies, AliveCor Inc., Nihon Kohden Corporation, EB Neuro S.p.A, FaceLake, PocketECG, Spandan, Dr Trust USA, Contec Health among others are the key players in the portable & mobile ECG devices market.
The North American region is estimated to hold the highest share in the portable & mobile ECG devices market.
The COVID-19 pandemic has encouraged individuals to direct their attention towards at-home healthcare devices. Individuals who require regular healthcare routine check-up have resorted to use portable and mobile ECG devices in order to reduce the risk of catching the virus. Doctors and the medical staff have also promoted the usage of in-home healthcare devices in order to reduce the burden of the healthcare sector, which was facing staff and healthcare device shortages. Doctors can remotely access the data collected by the portable ECG device on their smartphones and other electronic devices. The rise in telemedicine has increased the usage of portable and mobile ECG devices and have made the lives of both doctors and patients easier. Manufacturers have found the pandemic situation to be a conducive environment for the production and sale of the devices.
The global portable & mobile ECG devices market is highly driven by a growing population of CVD patients who require daily monitoring, rising geriatric population, increasing usage of technology-based healthcare, increasing healthcare expenses and growing demand for in-home healthcare devices.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius